Inobe Y, Kugiyama K, Miyagi H, Ohgushi M, Tomiguchi S, Takahashi M, Yasue H
Department of Radiology, Kumamoto University School of Medicine, Honjo, Japan.
Am Heart J. 1997 Jul;134(1):112-8. doi: 10.1016/s0002-8703(97)70114-5.
Quantitative analysis of iodine 123 metaiodobenzylguanidine (MIBG) myocardial tomographic imaging showed that the regional uptake reduction and abnormally high washout of MIBG in the myocardial territories of the coronary artery with spasm were observed in 33 (75%) and in 30 (68%) of 44 patients with coronary spastic angina, whereas it was observed in two (7%) and in four (15%) of 27 control subjects, respectively. The patients with higher disease activity of the anginal attack and those with life-threatening ventricular arrhythmias were frequently associated with either the uptake reduction or the abnormally high washout of MIBG (91% in patients with high disease activity, 100% in patients with ventricular arrhythmias). The repeated studies of MIBG myocardial tomographic imaging at 2 and 6 months after suppression of anginal attacks by medical treatments showed that the scintigraphic abnormalities still remained in 85% of the patients at 2 months and 32% at 6 months. Thus the abnormalities in sympathetic nervous system assessed with MIBG scintigraphy has been shown to be highly associated with patients with coronary arteries with spasm, particularly high-risk patients, and lasted for several months despite suppression of anginal attack.
对123碘间碘苄胍(MIBG)心肌断层显像进行定量分析显示,44例冠状动脉痉挛性心绞痛患者中,33例(75%)出现痉挛冠状动脉心肌区域MIBG摄取减少,30例(68%)出现MIBG异常高洗脱,而27例对照者中分别有2例(7%)和4例(15%)出现上述情况。心绞痛发作疾病活动度较高的患者以及有危及生命的室性心律失常的患者,常伴有MIBG摄取减少或异常高洗脱(疾病活动度高的患者中占91%,室性心律失常患者中占100%)。药物治疗抑制心绞痛发作后2个月和6个月对MIBG心肌断层显像进行重复研究显示,2个月时85%的患者仍存在闪烁显像异常,6个月时为32%。因此,MIBG闪烁显像评估的交感神经系统异常与冠状动脉痉挛患者,尤其是高危患者高度相关,并且尽管心绞痛发作得到抑制,但这种异常仍持续数月。